Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
Mori M, Kovalenko L, Malancona S, Saladini F, De Forni D, Pires M, Humbert N, Real E, Botzanowski T, Cianférani S, Giannini A, Dasso Lang MC, Cugia G, Poddesu B, Lori F, Zazzi M, Harper S, Summa V, Mely Y, Botta M. Mori M, et al. Among authors: pires m. ACS Chem Biol. 2018 Jan 19;13(1):253-266. doi: 10.1021/acschembio.7b00907. Epub 2017 Dec 28. ACS Chem Biol. 2018. PMID: 29235845
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
Humbert N, Kovalenko L, Saladini F, Giannini A, Pires M, Botzanowski T, Cherenok S, Boudier C, Sharma KK, Real E, Zaporozhets OA, Cianférani S, Seguin-Devaux C, Poggialini F, Botta M, Zazzi M, Kalchenko VI, Mori M, Mély Y. Humbert N, et al. Among authors: pires m. ACS Infect Dis. 2020 Apr 10;6(4):687-702. doi: 10.1021/acsinfecdis.9b00290. Epub 2020 Feb 21. ACS Infect Dis. 2020. PMID: 32045204
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.
Malancona S, Mori M, Fezzardi P, Santoriello M, Basta A, Nibbio M, Kovalenko L, Speziale R, Battista MR, Cellucci A, Gennari N, Monteagudo E, Di Marco A, Giannini A, Sharma R, Pires M, Real E, Zazzi M, Dasso Lang MC, De Forni D, Saladini F, Mely Y, Summa V, Harper S, Botta M. Malancona S, et al. Among authors: pires m. ACS Med Chem Lett. 2020 Mar 19;11(5):766-772. doi: 10.1021/acsmedchemlett.9b00608. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435383 Free PMC article.
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.
Valerie NCK, Sanjiv K, Mortusewicz O, Zhang SM, Alam S, Pires MJ, Stigsdotter H, Rasti A, Langelier MF, Rehling D, Throup A, Purewal-Sidhu O, Desroses M, Onireti J, Wakchaure P, Almlöf I, Boström J, Bevc L, Benzi G, Stenmark P, Pascal JM, Helleday T, Page BDG, Altun M. Valerie NCK, et al. Among authors: pires mj. Nat Commun. 2024 Dec 6;15(1):10347. doi: 10.1038/s41467-024-54415-7. Nat Commun. 2024. PMID: 39643609 Free PMC article.
Parrondo's effects with aperiodic protocols.
Pires MA, Pinto EP, da Silva RN, Duarte Queirós SM. Pires MA, et al. Chaos. 2024 Dec 1;34(12):123126. doi: 10.1063/5.0233604. Chaos. 2024. PMID: 39630929
881 results